StockData
Pasithea Therapeutics Corp. logo

Pasithea Therapeutics Corp. (KTTA) stock

KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.51+0.08 (+17.64%)

Close on Nov 18, 2026Market cap $17.07MP/E –Yield –

Pasithea Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Pasithea Therapeutics's market cap was $17.78M on Nov 11, 2026, against $10.94M a year earlier. Over the last 5 years it ranged from $1.62M to $33.64M, with a median of $10.94M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$17.78M+85.1%
2025Dec 31, 2025$9.60M+191.7%
2024Dec 31, 2024$3.29M-57.3%
2023Dec 29, 2023$7.71M-54.7%
2022Dec 30, 2022$17.04M-27.1%
2021Dec 31, 2021$23.38M–

More Pasithea Therapeutics figures

See a number that looks wrong?